CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging margins.

The latest trading session saw CVS Health (CVS) ending at $45.78, denoting a -0.09% adjustment from its last day's close. This change was narrower than the S&P 500's 1.11% loss on the day. Meanwhile, ...

Shares of CVS Health Corp. CVS slid 0.09% to $45.78 Tuesday, on what proved to be an all-around poor trading session for the ...

To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over ...

Zydus Lifesciences announced that it has entered into an agreement with CVS Caremark, a CVS Health (CVS) company, to add Zituvio, Zituvimet and ...

Allen Lutz, an analyst from Bank of America Securities, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price ...

Shares of CVS Health Corp. CVS inched 0.11% higher to $45.82 Monday, on what proved to be an all-around mixed trading session ...

Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $68.07, accompanied by ...

All of the commercial prescriptions dispensed at CVS pharmacies will be processed through its CostVantage reimbursement model ...

Aetna, the health, medical and benefits insurance unit of CVS Health, is back in the insurance-linked securities (ILS) market and seeking what could become its largest issuance in the long-standing ...

CVS Health has been named as a Top 25 dividend stock, according the most recent Dividend Channel "DividendRank" report.

CVS Health has announced that starting this year, all commercial prescriptions dispensed through CVS Pharmacy will be contracted through its new CVS CostVantage reimbursement model.